Risperidone Pellets

(Product under development)
Risperidone PelletsRisperidone (pronounced ris-pair-ih-doan) is a second generation or atypical antipsychotic, sold under the trade name (Risperdal).

It is used to treat schizophrenia (including adolescent schizophrenia), schizoaffective disorder, the mixed and manic states associated with bipolar disorder, and irritability in people with autism.

It is associated with significant weight gain and metabolic problems, as well as tardive dyskinesia and neuroleptic malignant syndrome. The drug was developed by Janssen-Cilag and first released in 1994.

Available Form:
Risperidone Pellets
Risperidone Granules

Umang Pharmatech equipments used for production of Risperidone Pellets:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Risperidone Pellets
Systematic (IUPAC) Name
Risperidone Pellets
Risperidone Pellets
Chemical data
CAS number : 106266-06-2
ATC code : N05AX08
PubChem : CID 5073
IUPHAR ligand : 96
DrugBank : DB00734
ChemSpider : 4895
KEGG : D00426
ChEBI : CHEBI:8871
Formula : C23H27FN4O2
Mol. mass : 410.485 g/mol

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech